Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer

Biliary tract cancer (BTC) is an uncommon and aggressive neoplasm, with most patients presenting in an advanced stage. Systemic chemotherapy is the limited treatment available but is unsatisfactory, while targeted therapy is still awaiting validation from clinical trials. Given the potential effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Seesaha, Poshita-Kumari, Wang, Kang-Xin, Wang, Guo-Qun, Cui, Ting-Yun, Zhao, Feng-Jiao, Pan, Lan-Lan, Li, Xiang-Cheng, Shu, Yong-Qian, Chen, Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966382/
https://www.ncbi.nlm.nih.gov/pubmed/33737812
http://dx.doi.org/10.2147/OTT.S269671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966382/
https://www.ncbi.nlm.nih.gov/pubmed/33737812
http://dx.doi.org/10.2147/OTT.S269671

Ejemplares similares